Report Detail
Pain Management and Surgical Devices Global Market - Forecast to 2025
- RnM2895592 |
- 12 March, 2020 |
- Global |
- 385 Pages |
- IQ4I Research & Consultancy |
- Medical Devices & Consumables
Pain is a debilitating condition, which can arise from arthritis, cancer, fibromyalgia and trauma, which includes neuropathic pain and nociceptive pain. This report focuses on treating various pain conditions with electrotherapy devices, ablation devices and surgical procedures. Electrotherapy devices include Spinal cord stimulator, peripheral nerve stimulator, TENS and NMES devices. These devices use electricity to treat pain by blocking the pain signals passing from nerve to brain. Surgical procedures such as kyphoplasty and vertebroplasty are used to treat pain caused by degenerative disc disease, whereas ablation procedures such as Radiofrequency ablation and Cryoablation are used to treat chronic pain and cancer pain by damaging pain causing nerve tissue. Ablation procedure damages the nerve that causes the pain and stops the transmission of pain signals to the brain. Several other devices like spacers, screws and artificial discs are used to treat back pain and neck pain caused by degenerative disc disease.
According to IQ4I analysis, the pain management and surgical devices global market is expected to grow at a high single digit CAGR to reach $8,824.7 million by 2025. The pain management and surgical devices market is mainly segmented by products, treatment type, application, end-users and by geography.
Based on the products market is segmented into pain devices and pain surgery, among this pain devices accounted the largest revenue in 2018 and is expected to grow at a high single digit CAGR from 2018 to 2025. Pain devices segment is further classified into internal pain devices and external pain devices. Among the internal pain devices, spinal cord stimulator accounted the largest revenue in 2018 and is projected to grow at a high single digit CAGR from 2018 to 2025. Among the external pain devices, TENS is accounted for largest revenue in 2018 and is expected to grow at a low single digit CAGR from 2018 to 2025, other external pain device segment include ultrasound therapy, photobiomodulation therapy, microwave therapy, short wave therapy, vegus nerve stimulation therapy and is expected to grow at a low single digit CAGR from 2018 to 2025. Pain surgery segment is divided into Kyphoplasty and vertebroplasty, fixation devices, artificial disc replacement and ablation. Among this kyphoplasty and vertebroplasty accounted the largest revenue in 2018 and is expected to grow at a mid single digit CAGR from 2018 to 2025, artificial disc replacement is projected to grow at a high single digit CAGR from 2018 to 2025. In pain surgery, ablation segment is further classified into radiofrequency ablation and cryoablation. Among this, radiofrequency ablation accounted the largest revenue and is projected to grow at a mid single digit CAGR from 2018 to 2025. Cryoablation is expected to grow at a high single digit CAGR from 2018 to 2025.
Based on the treatment type, pain management and surgical devices are classified into Invasive and non invasive. Among this, invasive devices accounted the largest revenue in 2018 and expected to grow at a high single digit CAGR from 2018 to 2025.
The applications segment in the pain management and surgical device market is classified into neuropathic pain, cancer pain, failed back surgery syndrome (FBSS), musculoskeletal disorder (MSD) and other pain, Among these applications, MSD holds the highest share in 2018, and expected to grow at a high single digit CAGR from 2018 to 2025, due to increase in incidence of musculoskeletal disorders.
Based on end-users, pain management and surgical devices market is segmented into hospitals, ambulatory surgical centers, pain management centers and others. In this segment, hospitals held the highest share in 2018, and expected to grow at a high single digit CAGR from 2018 to 2025.
Pain management and surgical devices geographic market is segmented into four major regions namely North America, Europe, Asia Pacific and Rest of World (ROW). North American region commanded the largest revenue in 2018 and expected to grow at a mid single digit CAGR. However, Asia-Pacific is expected to grow at high single digit CAGR from 2018 to 2025.
Major players in pain management devices and surgical devices are Abbot Laboratories (U.S.), Boston Scientific (U.S.), Medtronic Inc. (Ireland), Avanos Medical Inc. (Halyard health Inc.) (U.S.), Nevrocorp (U.S.), Nuvectra corporation (U.S.), Stryker Corporation (U.S.), Johnson and Johnson (DePuy synthes), (U.S.), Merit medicals (U.S.), DJO Finance Ltd. (Chattanooga) (U.S.).
The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
• North America
o U.S.
o Rest of North America
• Europe
o Germany
o France
o U.K.
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Rest of APAC
• Rest of the World (RoW)
o Brazil
o Rest of Latin America
o Middle East and Others
1 EXECUTIVE SUMMARY 25
2 INTRODUCTION 30
- 2.1 KEY TAKEAWAYS 30
- 2.2 SCOPE OF THE REPORT 31
- 2.3 REPORT DESCRIPTION 31
- 2.4 MARKETS COVERED 34
- 2.5 STAKEHOLDERS 35
- 2.6 RESEARCH METHODOLOGY 36
- 2.6.1 MARKET SIZE ESTIMATION 37
- 2.6.2 MARKET BREAKDOWN AND DATA TRIANGULATION 40
- 2.6.3 SECONDARY SOURCES 41
- 2.6.4 PRIMARY SOURCES 42
- 2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES 42
- 2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES 43
- 2.6.7 ASSUMPTIONS 43
3 MARKET ANALYSIS 45
- 3.1 INTRODUCTION 45
- 3.2 MARKET SEGMENTATION 46
- 3.3 FACTORS INFLUENCING MARKET 48
- 3.3.1 DRIVERS AND OPPORTUNITIES 49
- 3.3.1.1 Rise in chronic diseases and pain disorders 49
- 3.3.1.2 Adverse effects of pain medicines and stringent regulations to limits opioids medicine 49
- 3.3.1.3 Increase in a geriatric population with chronic pain 50
- 3.3.1.4 Technological advancement 51
- 3.3.1.5 Reimbursement in pain management devices 52
- 3.3.2 RESTRAINTS AND THREATS 52
- 3.3.2.1 Availability of alternative therapies 52
- 3.3.2.2 Contraindications of pain management devices 53
- 3.3.2.3 High cost of pain management devices 53
- 3.3.2.4 Stringent regulations for the approvals of products 54
- 3.3.1 DRIVERS AND OPPORTUNITIES 49
- 3.4 REGULATORY AFFAIRS 55
- 3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION 55
- 3.4.1.1 ISO 9001: 2015 quality management system 55
- 3.4.2 U.S. 56
- 3.4.3 CANADA 56
- 3.4.4 EUROPE 57
- 3.4.5 JAPAN 57
- 3.4.6 CHINA 58
- 3.4.7 INDIA 58
- 3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION 55
- 3.5 PATENT TRENDS 60
- 3.5.1 INTRODUCTION 60
- 3.5.2 PAIN MANAGEMENT AND SURGICAL DEVICES PATENT TREND 61
- 3.6 TECHNOLOGICAL ADVANCEMENTS 62
- 3.6.1 INTRODUCTION 62
- 3.6.2 NANO-ELECTRODES AND WIRELESS TECHNOLOGY FOR NEUROMODULATION 62
- 3.6.3 POINT OF CARE ULTRASOUND (POCUS) NEUROMODULATION 63
- 3.6.4 MINIATURIZATION OF PAIN MANAGEMENT DEVICES 63
- 3.6.5 TECHNOLOGICAL CONVERGENCE OF PAIN MANAGEMENT DEVICES 64
- 3.7 PORTER’S FIVE FORCE ANALYSIS 65
- 3.7.1 THREAT OF NEW ENTRANTS 66
- 3.7.2 THREAT OF SUBSTITUTES 66
- 3.7.3 BARGAINING POWER OF SUPPLIERS 66
- 3.7.4 BARGAINING POWER OF BUYERS 67
- 3.7.5 COMPETITIVE RIVALRY 67
- 3.8 SUPPLY CHAIN ANALYSIS 68
- 3.9 MARKET SHARE ANALYSIS BY MAJOR PLAYERS 72
- 3.9.1 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET SHARE ANALYSIS 72
- 3.9.2 MARKET SHARE ANALYSIS OF SPINAL CORD STIMULATOR BY MAJOR PLAYERS 75
- 3.9.3 MARKET SHARE ANALYSIS OF RADIOFREQUENCY ABLATION DEVICES BY MAJOR PLAYERS 77
- 3.9.4 MARKET SHARE ANALYSIS OF KYPHOPLASTY AND VERTEBROPLASTY DEVICES BY MAJOR PLAYERS 79
- 3.10 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET PENETRATION AND NUMBER OF UNIT SOLD 81
- 3.10.1 PAIN MANAGEMENT AND SURGICAL DEVICES MARKET PENETRATION 82
- 3.11 PAIN MANAGEMNENT AND SURGICAL DEVICES NUMBER OF UNITS
BY REGION 83
- 3.11.1 SPINAL CORD STIMULATOR NUMBER OF UNITS BY REGION
(2017-2025) (NO’S) 83
- 3.11.2 RADIOFREQUENCY ABLATIO DEVICES NUMBER OF UNITS BY REGION 84
- 3.11.3 ARTIFICIAL DISC REPLACEMENT DEVICES NUMBER OF UNITS
BY REGION 85
- 3.12 PAIN MANAGEMENT AND SURGICAL DEVICES COMPANY COMPARISON
TABLE BY PRODUCTS 86
- 3.12.1 SPINAL CORD STIMULATOR DEVICES 86
- 3.12.2 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATOR (TENS) 87
- 3.12.3 ABLATION DEVICES 89
- 3.12.4 KYPHOPLASTY & VERTEBROPLASTY 90
- 3.12.5 FIXATION DEVICES AND ARTIFICIAL DISC REPLACEMENT 91
- 3.12.6 OTHER PAIN MANAGEMENT DEVICES 93
4 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET,
BY PRODUCT 97
- 4.1 INTRODUCTION 97
- 4.2 PAIN DEVICES 102
- 4.2.1 INTERNAL PAIN DEVICES 107
- 4.2.1.1 Spinal cord stimulator 112
- 4.2.1.2 Peripheral nerve stimulator 114
- 4.2.1.3 Other internal pain devices 116
- 4.2.2 EXTERNAL PAIN DEVICES 119
- 4.2.2.1 Transcutaneous electrical nerve stimulation (TENS) 124
- 4.2.2.2 Neuromuscular electrical stimulation (NMES) 126
- 4.2.2.3 Other external pain devices 128
- 4.2.2.3.1 Ultrasound 132
- 4.2.2.3.2 Photobiomodulation therapy 134
- 4.2.2.3.3 Other therapy 136
- 4.3 PAIN SURGERY 138
- 4.3.1 KYPHOPLASTY & VERTEBROPLASTY 143
- 4.3.2 FIXATION DEVICES 145
- 4.3.3 ARTIFICIAL DISC REPLACEMENT 147
- 4.3.4 ABLATION 149
- 4.3.4.1 Radiofrequency ablation 151
- 4.3.4.2 Cryoablation 153
5 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET,
BY TREATMENT TYPE 155
- 5.1 INTRODUCTION 155
- 5.2 INVASIVE PAIN MANAGEMENT AND SURGICAL DEVICES 158
- 5.3 NON-INVASIVE PAIN MANAGEMENT AND SURGICAL DEVICES 161
6 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET,
BY APPLICATION 164
- 6.1 INTRODUCTION 164
- 6.2 NEUROPATHIC PAIN 167
- 6.3 CANCER PAIN 169
- 6.4 FAILED BACK SURGERY SYNDROME (FBSS) 171
- 6.5 MUSCULOSKELETAL DISORDERS (MSD) 173
- 6.6 OTHER PAIN 175
7 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET,
BY END-USERS 177
- 7.1 INTRODUCTION 177
- 7.2 HOSPITALS 180
- 7.3 AMBULATORY SURGERY CENTER 182
- 7.4 PAIN MANAGEMENT CENTERS & OTHERS 184
8 REGIONAL ANALYSIS 186
- 8.1 INTRODUCTION 186
- 8.2 NORTH AMERICA 190
- 8.2.1 U.S. 205
- 8.2.2 REST OF NORTH AMERICA 209
- 8.3 EUROPE 213
- 8.3.1 GERMANY 228
- 8.3.2 FRANCE 232
- 8.3.3 U.K. 236
- 8.3.4 REST OF EUROPE 240
- 8.4 APAC 244
- 8.4.1 JAPAN 259
- 8.4.2 CHINA 263
- 8.4.3 INDIA 267
- 8.4.4 REST OF APAC 271
- 8.5 ROW 275
- 8.5.1 BRAZIL 290
- 8.5.2 REST OF LATAM 294
- 8.5.3 MIDDLE EAST & OTHERS 298
9 COMPETITIVE LANDSCAPE 302
- 9.1 INTRODUCTION 302
- 9.2 APPROVALS 303
- 9.3 NEW PRODUCT LAUNCH 305
- 9.4 MERGERS AND ACQUISITIONS 307
10 MAJOR COMPANIES 310
- 10.1 ABBOTT LABORATORIES 310
- 10.1.1 OVERVIEW 310
- 10.1.2 FINANCIALS 311
- 10.1.3 PRODUCT PORTFOLIO 315
- 10.1.4 KEY DEVELOPMENTS 315
- 10.1.5 BUSINESS STRATEGY 316
- 10.1.6 SWOT ANALYSIS 317
- 10.2 AVANOS MEDICAL, INC. (HALYARD HEALTH, INC.) 318
- 10.2.1 OVERVIEW 318
- 10.2.2 FINANCIALS 319
- 10.2.3 PRODUCT PORTFOLIO 321
- 10.2.4 KEY DEVELOPMENTS 321
- 10.2.5 BUSINESS STRATEGY 322
- 10.2.6 SWOT ANALYSIS 323
- 10.3 BOSTON SCIENTIFIC CORPOARTION 324
- 10.3.1 OVERVIEW 324
- 10.3.2 FINANCIALS 325
- 10.3.3 PRODUCT PORTFOLIO 329
- 10.3.4 KEY DEVELOPMENTS 329
- 10.3.5 BUSINESS STRATEGY 330
- 10.3.6 SWOT ANALYSIS 331
- 10.4 DJO GLOBAL 332
- 10.4.1 OVERVIEW 332
- 10.4.2 FINANCIALS 333
- 10.4.3 PRODUCT PORTFOLIO 336
- 10.4.4 KEY DEVELOPMENTS 336
- 10.4.5 BUSINESS STRATEGY 337
- 10.4.6 SWOT ANALYSIS 338
- 10.5 JOHNSON AND JOHNSON 339
- 10.5.1 OVERVIEW 339
- 10.5.2 FINANCIALS 340
- 10.5.3 PRODUCT PORTFOLIO 345
- 10.5.4 KEY DEVELOPMENTS 346
- 10.5.5 BUSINESS STRATEGY 347
- 10.5.6 SWOT ANALYSIS 348
- 10.6 MEDTRONIC, PLC 349
- 10.6.1 OVERVIEW 349
- 10.6.2 FINANCIALS 350
- 10.6.3 PRODUCT PORTFOLIO 354
- 10.6.4 KEY DEVELOPMENTS 354
- 10.6.5 BUSINESS STRATEGY 355
- 10.6.6 SWOT ANALYSIS 356
- 10.7 MERIT MEDICALS SYSTEM INC. 357
- 10.7.1 OVERVIEW 357
- 10.7.2 FINANCIALS 358
- 10.7.3 PRODUCT PORTFOLIO 361
- 10.7.4 KEY DEVELOPMENTS 361
- 10.7.5 BUSINESS STRATEGY 362
- 10.7.6 SWOT ANALYSIS 363
- 10.8 NEVROCORP 364
- 10.8.1 OVERVIEW 364
- 10.8.2 FINANCIALS 365
- 10.8.3 PRODUCT PORTFOLIO 367
- 10.8.4 KEY DEVELOPMENTS 367
- 10.8.5 BUSINESS STRATEGY 368
- 10.8.6 SWOT ANALYSIS 369
- 10.9 NUVECTRA 370
- 10.9.1 OVERVIEW 370
- 10.9.2 FINANCIALS 371
- 10.9.3 PRODUCT PORTFOLIO 375
- 10.9.4 KEY DEVELOPMENTS 375
- 10.9.5 BUSINESS STRATEGY 375
- 10.9.6 SWOT ANALYSIS 376
- 10.10 STRYKER CORPORATION 377
- 10.10.1 OVERVIEW 377
- 10.10.2 FINANCIALS 378
- 10.10.3 PRODUCT PORTFOLIO 382
- 10.10.4 KEY DEVELOPMENTS 382
- 10.10.5 BUSINESS STRATEGY 383
- 4.2.1 INTERNAL PAIN DEVICES 107
Summary:
Get latest Market Research Reports on Pain Management and Surgical Devices . Industry analysis & Market Report on Pain Management and Surgical Devices is a syndicated market report, published as Pain Management and Surgical Devices Global Market - Forecast to 2025. It is complete Research Study and Industry Analysis of Pain Management and Surgical Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
